MerckCollaborateswithVersantVenturestoLaunchSaturnusBiotoAdvanceTreatmentsforRareGeneticCardiomyopathies
===2026/6/24 10:28:44===
arch productivity and the output of its pipeline sustainably, focusing on indications that can be derisked through proper preclinical and early clinical testing to ensure that more patients gain access to effective treatments.
About Merck
Merck, a leading science and technology company, operates across life science, healthcare and electronics. More than 62,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From providing products and services that accelerate drug development and manufacturing as well as discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2025, Merck generated sales of € 21.1 billion in 65 countries.
Scientific exploration and responsible entrepreneurship have been key to Merck’s technological and scientific advances. This is how Merck has thrive
=*=*=*=*=*=
当前为第4/5页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页